We recognize that many great ideas will come from the vast research community beyond Calico and that effective collaborations will be critical to achieving success. Together with Calico’s scientists, our experienced business development team identifies promising research areas that complement and enhance our internal efforts. Our scientific approach enables us to develop and cultivate important relationships with leaders in the field of aging and related diseases, with a view to establishing productive collaborations. Additionally, we are responsible for maintaining and managing our partnerships to ensure that the collaboration is successful and that our partners' needs are met. For additional information about partnering with Calico, see here.
A fundamental goal of Calico is to gain new insights into the biology of aging. We appreciate both the challenge and opportunity of leveraging these new insights towards the treatment of aging-related diseases. We explore fundamental mechanisms that could have applicability to a broad range of disease indications and seek to identify the therapeutic opportunities most likely to benefit patients. Our project team leaders combine strong scientific training and drug development experience to create and execute strategies for development of our therapeutic candidates. This is done in a multi-disciplinary team setting involving Calico and our collaborators to access the best expertise and capabilities to optimize our likelihood of success.